Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Novel 200 mg Ibuprofen Medicated Plaster
NCT03694587Phase 1Completed
- Sponsor
- Medherant
- Start
- Sep 2018
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ibuprofen in pain (2 arms), sponsored by Medherant. Primary endpoints: Area Under the Curve from time 0 to 12 hours, Area Under the Curve from time 0 to last measurable concentration at 5 days and 1 more. Started Sep 2018; status: completed.
02
Drugs
ibuprofen
03
Conditions
pain
Beyond the preview
Go deeper on NCT03694587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03694587.